A SECRET WEAPON FOR MBL77

Not all clients with CLL require therapy. Irrespective of all new developments, the iwCLL still recommends watchful observation for sufferers with asymptomatic disease.86 This advice relies on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 B